GlassScriptPhysician profile
Scot C Schultz
NPI 1609808385
$5,318.17
in general payments reported to CMS, 2019-2025
26 companies · $843 in 2025
The $843 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,004 · 2020: $609 · 2021: $917 · 2022: $593 · 2023: $613 · 2024: $739 · 2025: $843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,194.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,339.93 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Evoque, Mitris Resilia Mitral Valve |
| Abbott Laboratories | $730.38 | 2019-2025 | Epic, Navitor |
| Medtronic, INC. | $559.04 | 2021-2025 | Corevalve Evolut R, Penditure |
| Atricure, INC. | $556.93 | 2019-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Cvrx, INC. | $480.60 | 2020 | |
| Medtronic Vascular, INC. | $290.97 | 2019 | |
| Zimmer Biomet Holdings, INC. | $284.91 | 2021-2025 | Sternalock Blu System, A&E Medical / Sternalock Xp Rigid Fixation System, Sternalock 360 System |
| Boston Scientific Corporation | $157.55 | 2025 | Farapulse |
| Clearflow INC. | $135.81 | 2019 | |
| Medical Device Business Services, INC. | $124.09 | 2024 | Vistaseal |
| Livanova USA, INC. | $117.71 | 2019 | |
| Getinge USA Sales, LLC | $78.95 | 2021-2023 | Vasoview Hemopro 2 |
| Lexington Medical, INC. | $71.20 | 2023 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Intuitive Surgical, INC. | $70.90 | 2024 | |
| Alnylam Pharmaceuticals INC. | $52.27 | 2024-2025 | Onpattro |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $36.84 | 2022 | |
| Ethicon US, LLC | $32.12 | 2020 | |
| Abiomed | $30.57 | 2025 | |
| Merck Sharp & Dohme LLC | $26.09 | 2025 | Keytruda |
| Solventum Corporation | $25.67 | 2024 | Prevena |
| Baxter Healthcare | $23.76 | 2023 | |
| Lungpacer Medical USA INC | $22.97 | 2025 | Aeropace Neurostimulation Console |
| Kls-Martin L.P. | $22.70 | 2019 | |
| Arthrex, INC. | $19.54 | 2022 | |
| Biomerieux INC | $13.96 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scot Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.